As of April 16, 2025, Zealand Pharma (ZEAL.CO) has a market cap of $4.76 billion USD. According to our data, Zealand Pharma is ranked No.2611 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $4.76 B |
-37.78%
|
Dec 30, 2024 | $7.65 B |
91.72%
|
Dec 29, 2023 | $3.99 B |
85.30%
|
Dec 30, 2022 | $2.15 B |
38.80%
|
Dec 30, 2021 | $1.55 B |
-34.22%
|
Dec 30, 2020 | $2.36 B |
-6.29%
|
Dec 30, 2019 | $2.52 B |
185.68%
|
Dec 28, 2018 | $0.88 B |
-3.06%
|
Dec 29, 2017 | $0.91 B |
-20.19%
|
Dec 30, 2016 | $1.14 B |
-29.70%
|
Dec 30, 2015 | $1.62 B |
82.53%
|
Dec 30, 2014 | $0.89 B |
40.68%
|
Dec 30, 2013 | $0.63 B |
-29.76%
|
Dec 28, 2012 | $0.90 B |
47.37%
|
Dec 30, 2011 | $0.61 B |
-18.57%
|
Dec 30, 2010 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
Market Cap | = | ZEAL.CO Stock Price | * | ZEAL.CO Shares Outstanding |
= | $67.35 | * | 70.68 M | |
= | $4.76 B |